Cancer Care in the Digital Age: Redefining What Patients and Practitioners Need to Know

Apr 2
2 min read

AGTC Genomics is proud to participate in the Health Summit Asia 2026, a premier regional platform that brings together leaders from healthcare, academia, and technology to explore the future of medicine in an increasingly digital world.

The summit will be held on 21 May 2026 at the Kuala Lumpur Convention Centre (KLCC), Malaysia, gathering key stakeholders to address emerging trends and challenges in healthcare transformation.

The Digital Transformation of Cancer Care

Cancer care is undergoing a profound shift. Advances in genomics, artificial intelligence, and digital health technologies are reshaping how cancers are detected, diagnosed, and managed.

From early detection through liquid biopsy to comprehensive genomic profiling and real-time disease monitoring, precision medicine is enabling more targeted and personalized treatment strategies. At the same time, digital platforms are improving access to data, enhancing clinical decision-making, and enabling more coordinated care.

However, alongside these advancements comes a critical need to ensure that both patients and practitioners are equipped with the right knowledge to navigate this evolving landscape.

AGTC Genomics Perspective: Bridging Innovation and Clinical Practice

At the summit, our CEO, Prof. Chee-Onn Leong, will present a session titled:“Cancer Care in the Digital Age: What Patients and Practitioners Need to Know.”

This session will focus on translating innovation into practical clinical impact, highlighting key considerations such as:

Understanding Genomic Testing — When and how to use tests such as comprehensive gene profiling and liquid biopsy
Interpreting Data in Clinical Context — Moving from raw genomic data to actionable insights
Integrating Digital Tools into Care Pathways — Leveraging AI and digital platforms to support decision-making
Empowering Patients — Enhancing awareness and participation in personalized treatment strategies

From Technology to Impact

AGTC Genomics continues to play a leading role in advancing precision oncology in Southeast Asia. With a CAP-accredited and ISO-certified genomics laboratory in Malaysia, the company provides accessible and affordable genomic testing solutions designed for real-world clinical use.

By combining next-generation sequencing (NGS), bioinformatics, and digital technologies, AGTC Genomics aims to bridge the gap between cutting-edge innovation and everyday clinical practice—ensuring that patients benefit from the latest advancements in cancer care.

A Regional Platform for Collaboration

Health Summit Asia 2026 serves as an important platform to foster collaboration across the healthcare ecosystem. As cancer care becomes increasingly data-driven and multidisciplinary, partnerships between clinicians, researchers, technology providers, and industry will be essential to drive sustainable progress.

AGTC Genomics looks forward to contributing to these discussions and working alongside regional stakeholders to build a more connected, patient-centric healthcare system.